Carrier-Mediated Delivery of 9-(2-Phosphonylmethoxyethyl)Adenine to Parenchymal Liver Cells: a Novel Therapeutic Approach for Hepatitis B

Ítems similars

• Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation
  per: Bijsterbosch, Martin K., et al.
  Publicat: (2000)
• Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.
  per: Biessen, E A, et al.
  Publicat: (1999)
• Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
  per: Naesens, L, et al.
  Publicat: (1996)
• In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells.
  per: Bijsterbosch, M K, et al.
  Publicat: (1997)
• 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.
  per: Gangemi, J D, et al.
  Publicat: (1989)